What does PurposeBio do?

PurposeBio is a synthetic biology platform company founded in 2020 as a UCLA spin-out. Based in Los Angeles, California, the company focuses on developing proprietary oral enzyme therapeutics for cardiometabolic diseases, including fatty liver, high cholesterol, and obesity. PurposeBio aims to address significant unmet medical needs in a market affecting over 1 billion people. The company engineers innovative enzymes that target fat absorption and digestion in a specific, non-systemic manner. These oral therapies are designed to be safe, non-hormonal, and non-receptor targeting, offering precision and scalability across various metabolic diseases. PurposeBio holds exclusive patents from UCLA and is recognized for its impactful research and development efforts. The team consists of experts in synthetic biology and computer science, dedicated to improving global health outcomes.